Skip to main content

Table 1 Characteristics of the gout patients who responded to the questionnaire

From: Patients’ knowledge and beliefs concerning gout and its treatment: a population based study

Demographics

Total N = 240

Active gout N = 53

Inactive gout N = 187

P value

Age (N and%)

   

0.016

<65

81 (34)

12 (23)

69 (37)

 

65-74

93 (39)

17 (32)

76 (41)

 

75 or older

66 (28)

24 (45)

42 (22)

 

Gender (% male)

193 (80)

37 (70)

156 (83)

0.028

Race (N and%)

   

0.825

Caucasian

225 (94)

50 (94)

175 (94)

 

Native American

9 (4)

2 (4)

7 (4)

 

Hispanic

3 (1)

1 (2)

2 (1)

 

Black

2 (1)

0 (0)

2 (1)

 

Asian

1 (0)

0 (0)

1 (1)

 

Highest grade completed (N and%)

   

0.331

No high school degree

33 (14)

9 (18)

24 (13)

 

High school graduate

86 (36)

19 (37)

67 (36)

 

College

118 (50)

23 (45)

95 (51)

 

Health Behaviors

    

Current smoking (N and%)

13 (5)

3 (6)

10 (5)

0.929

Alcohol use* (N and%)

94 (39)

13 (25)

81 (43)

0.014

Associated Conditions

    

Dyslipidemia (N and%)

196 (82)

45 (85)

151 (82)

0.581

Hypertension (N and%)

185 (78)

44 (83)

141 (76)

0.295

Diabetes mellitus (N and%)

91 (38)

22 (42)

69 (37)

0.579

Coronary heart disease (N and%)

77 (32)

21 (40)

56 (30)

0.200

Renal disease (N and%)

43 (18)

12 (23)

31 (17)

0.327

Peripheral arterial disease (N and%)

21 (9)

8 (15)

13 (7)

0.069

Nephrolithiasis (N and%)

17 (7)

4 (8)

13 (7)

0.897

Gout history

    

Gout encounters (mean, ± SD)**

1 (2)

2 (3)

1 (2)

 

Cared for by a rheumatologist (N and%)

14 (6)

8 (19)

6 (4)

 

ULD dispensing (N and%) **

108 (47)

37 (70)

77 (42)

0.0004

Colchicine use (N and%)**

59 (26)

23 (43)

37 (21)

0.0011

Glucocorticoid use (N and%)**

44 (19)

19 (36)

26 (14)

0.0005

NSAID use (N and%)**

72 (32)

14 (26)

60 (33)

0.355

  1. * reports having 2 or more drinks of alcohol in the last 7 days.
  2. ** based on visits or dispensing of urate-lowering drugs (ULDs), colchicine, steroids and NSAIDs in the prior 12 months.